Ellex iTrack for MIGS

Illuminated, micron-scale microcatheter designed for MIGS

Designed for ABiC


Featuring a proprietary design, iTrack™ is the only illuminated, micron-scale microcatheter designed to viscodilate Schlemm’s canal during MIGS with ABiC(ab-interno canaloplasty). The stand-out feature of the iTrack™ is its illuminated tip, which allows you to monitor its location at all times to ensure you do not enter any of the collector channel ostia. It comprises a small gauge support wire to provide real-time, tactile feedback as you progress through Schlemm’s canal: this allows you to feel if the canal is tight, grainy or completely open. It also makes it possible for you to maneuver through tight areas of the canal. Additionally, you can precisely control the delivery of viscoelastic, as required, to overcome blockages or any areas of resistance.

iTrack Benefits

 
  • Comprehensive: treats trabecular meshwork, Schlemm's canal and collector channels
  • Restores natural outflow pathways with minimal tissue trauma
  • No permanent implant or stent
  • Patient selection criteria are similar to current MIGS procedure

Transscleral Visualization

Featuring an illuminated tip, the iTrack™ 250 microcatheter can be continuously monitored once it is inserted into Schlemm’s canal, ensuring it is directed as intended.

360 Degrees, With Ease

The unique design of the iTrack™ includes a rounded, atraumatic tip and a lubricious coating (similar to that used in cardiology). This design aids insertion and helps to prevent the iTrack™ from getting misdirected into the collector channels. A small-gauge wire, which ensures greater control during the procedure, further permits full circumferential viscodilation of the entire length of Schlemm’s canal.

Viscoelastic Injection

The iTrack™ 250 microcatheter features a 200-micron diameter shaft that is connected to an ophthalmic viscosurgical device (OVD) injector, which permits precise injection of viscoelastic during cannulation.

ABiC: A New Comprehensive MIGS


Performed as a stand-alone procedure or as an adjunct to cataract surgery, ABiC™ comprehensively restores the natural outflow pathways in mild-moderate glaucoma. Whereas other MIGS procedures treat only one aspect of aqueous outflow, ABiC™ comprehensively accesses, catheterizes, and viscodilates the trabecular meshwork, Schlemm’s canal, and importantly, the distal


outflow system, beginning with the collector channels. A restorative procedure, ABiC™ preserves tissue and does not require permanent placement of an implant in the eye.

Learn more about ABiC  

Rather than trying to mechanically change or bypass the pathway of aqueous outflow, ABiC acts to restore the natural outflow process by targeting all aspects of the outflow system. That is, the trabecular meshwork, Schlemm canal, and the collector channels. This is an important distinction of the procedure — especially considering that it is not always understood where the point of maximum resistance lies. It therefore makes sense to apply a procedure that comprehensively addresses the entire outflow system.

Mark J. Gallardo, MD

El Paso Eye Surgeons, Texas, USA

 
 

ABiC: A New MIGS on the Block

Mark J. Gallardo, MD EL Paso Eye Surgeons, USA

Play Video
 
 

ABiC: A New MIGS on the Block

Mark J. Gallardo, MD EL Paso Eye Surgeons, USA

Play Video
 
 
 

ABiC: An Evolution of Canaloplasty

Mahmoud A. Khaimi, MD Dean McGee Eye Institute, USA

Play Video
 
 

ABiC: A New, Comprehensive MIGS

Mahmoud A. Khaimi, MD Dean McGee Eye Institute, USA

Play Video

Ellex iTrack Brochure

DOWNLOAD

 

Related Products